TissGeneSummary for DFNB59 |
Gene summary |
Basic gene information | Gene symbol | DFNB59 |
Gene name | deafness, autosomal recessive 59 | |
Synonyms | PJVK | |
Cytomap | UCSC genome browser: 2q31.2 | |
Type of gene | protein-coding | |
RefGenes | NM_001042702.3, | |
Description | autosomal recessive deafness type 59 proteinpejvakin | |
Modification date | 20141207 | |
dbXrefs | MIM : 610219 | |
HGNC : HGNC | ||
Ensembl : ENSG00000204311 | ||
Vega : OTTHUMG00000154425 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_DFNB59 | |
BioGPS: 494513 | ||
Pathway | NCI Pathway Interaction Database: DFNB59 | |
KEGG: DFNB59 | ||
REACTOME: DFNB59 | ||
Pathway Commons: DFNB59 | ||
Context | iHOP: DFNB59 | |
ligand binding site mutation search in PubMed: DFNB59 | ||
UCL Cancer Institute: DFNB59 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of DFNB59 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for DFNB59 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
BRCA | -1.010842163 | 0.514847311 | -1.525689474 | 2.71E-33 | 4.39E-32 |
KICH | -1.460874829 | 0.021225171 | -1.4821 | 3.12E-11 | 2.70E-10 |
PRAD | -1.832833829 | -0.793722291 | -1.039111538 | 4.65E-11 | 1.13E-09 |
Top |
TissGene-miRNA for DFNB59 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for DFNB59 |
TissGeneSNV for DFNB59 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.S170L | ESCA | 1 |
p.R319K | SKCM | 1 |
p.P55H | UCEC | 1 |
p.K197N | LGG | 1 |
p.L273I | GBM | 1 |
p.R167Q | UCEC | 1 |
p.A340E | COAD | 1 |
p.R265G | COAD | 1 |
p.G176V | LUAD | 1 |
p.R178* | BLCA | 1 |
p.G313* | UCEC | 1 |
p.V100I | KIRC | 1 |
p.D261N | SKCM | 1 |
p.R255T | LIHC | 1 |
p.G233E | SKCM | 1 |
p.V262A | STAD | 1 |
p.F2C | UCEC | 1 |
p.S143C | LUAD | 1 |
p.H185Y | SKCM | 1 |
p.D60N | SKCM | 1 |
p.R319S | THYM | 1 |
p.G90E | SKCM | 1 |
p.A340V | STAD | 1 |
p.L130F | LGG | 1 |
p.R319M | COAD | 1 |
p.D279N | HNSC | 1 |
p.G17E | SKCM | 1 |
p.E238K | CESC | 1 |
p.N250D | LGG | 1 |
p.G101R | LUSC | 1 |
p.D29N | CHOL | 1 |
p.S329F | UCEC | 1 |
p.G194E | SKCM | 1 |
p.R296Q | UCEC | 1 |
p.R136_splice | LUSC | 1 |
p.P202S | SKCM | 1 |
p.S109C | ESCA | 1 |
p.R258G | DLBC | 1 |
p.R183W | PRAD | 1 |
p.L224V | UCEC | 1 |
p.G313X | CHOL | 1 |
p.G313E | LUAD | 1 |
p.T239M | LUAD | 1 |
p.D141N | STAD | 1 |
Top |
TissGeneCNV for DFNB59 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for DFNB59 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for DFNB59 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for DFNB59 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for DFNB59 |
TissGeneDrug for DFNB59 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for DFNB59 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0155552 | Hearing Loss, Mixed Conductive-Sensorineural | 5 | BeFree |
umls:C1852271 | Auditory neuropathy | 5 | BeFree |
umls:C1384666 | hearing impairment | 3 | GAD,LHGDN |
umls:C3711374 | Nonsyndromic Deafness | 3 | BeFree |
umls:C0011053 | Deafness | 2 | CTD_human,GAD |
umls:C1857744 | DEAFNESS, AUTOSOMAL RECESSIVE 59 | 2 | CLINVAR,CTD_human,MGD,UNIPROT |
umls:C2732267 | Auditory neuropathy spectrum disorder | 2 | BeFree |
umls:C0018772 | Hearing Loss, Partial | 1 | GAD |
umls:C3887873 | Hearing Loss | 1 | GAD |